- Report
- June 2022
- 90 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- October 2021
- 78 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- July 2020
Europe
From €8187EUR$8,995USD£6,954GBP
- Report
- March 2025
- 86 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- September 2024
- 98 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- May 2023
- 34 Pages
Russia, India, China, ... Russia, India, China, Brazil
From €3636EUR$3,995USD£3,088GBP
- Report
- July 2024
- 216 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- March 2023
- 297 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- June 2021
- 266 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
The Gastric Balloon is a medical device used to treat obesity. It is a non-surgical procedure that involves the insertion of a balloon into the stomach, which is then filled with a saline solution. The balloon takes up space in the stomach, reducing the amount of food that can be consumed and helping to reduce hunger. The procedure is typically done in an outpatient setting and is reversible.
The Gastric Balloon market is a growing segment of the medical device industry. It is a minimally invasive procedure that is becoming increasingly popular as an alternative to more invasive bariatric surgeries. The procedure is relatively safe and has a high success rate in helping patients to lose weight.
Some companies in the Gastric Balloon market include Apollo Endosurgery, ReShape Medical, Allurion Technologies, and Obalon Therapeutics. Show Less Read more
